BRTX
BioRestorative Therapies, Inc.
Key Financials
Operating Income
$-15647132
↓ 35.4%
Revenue
$359700
↓ 10.3%
EPS (Diluted)
$-1.58
↓ 36.2%
Total Assets
$4.1M
↓ 66.8%
Cash & Equivalents
$1.5M
↑ 175.8%
Total Liabilities
$3.7M
↑ 252.5%
Gross Profit
$335856
↓ 9.9%
Shareholders' Equity
$356744.00
↓ 95.8%
Recent SEC Filings
| Form Type | Filed Date | Link |
|---|---|---|
| 8-K | 9/11/2026 | View on SEC |
| 8-K/A | 9/10/2026 | View on SEC |
| 8-K | 9/2/2026 | View on SEC |
| 8-K | 9/2/2026 | View on SEC |
| 8-K | 8/25/2026 | View on SEC |
| NT 10-Q | 8/14/2026 | View on SEC |
| 8-K | 8/14/2026 | View on SEC |
| SCHEDULE 13G/A | 8/3/2026 | View on SEC |
| 3 | 7/30/2026 | View on SEC |
| 3 | 7/24/2026 | View on SEC |
Company Information
| Field | Value |
|---|---|
| Ticker | BRTX |
| Company Name | BioRestorative Therapies, Inc. |
| CIK | 1505497 |
| Sector | Services-Misc Health & Allied Services, NEC |
| Industry | Non-accelerated filer Smaller reporting company |
| Exchange | Nasdaq |
| SIC Code | 8090 |
| SIC Description | Services-Misc Health & Allied Services, NEC |
| Entity Type | operating |
| Fiscal Year End | 1231 |
| State of Incorporation | NV |
| Phone | (631) 760-8100 |